Showing results 18 to 25 of 25
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Optimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patients Proceeding/Conference:Journal of Hepatology | 2006 | ||
Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year Proceeding/Conference:Journal of Hepatology | 2006 | ||
2002 | |||
Prolonged efficacy and safety of 3 years of continuous telbivudine treatment in pooled data from globe and 015 studies in chronic hepatitis B patients Proceeding/Conference:Journal of Hepatology | 2009 | ||
2004 | |||
Telbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial Proceeding/Conference:Hepatology | 2005 | ||
Telbivudine improves renal function in patients with chronic hepatitis B Journal:Gastroenterology | 2014 | ||
Telbivudine versus lamivudine in patients with chronic hepatitis B Journal:New England Journal of Medicine | 2007 |